BRIEF-Proteon Therapeutics Qtrly loss per share $0.48 Aug 8 Proteon Therapeutics Inc :* Proteon Therapeutics announces second quarter 2016 financial results * Line data from first phase 3 study, patency-1, this december Source text for Eikon: Further company coverage:
Flux Party seeks to be the bitcoin of Australian politics
FDA approves Baxalta's drug for rare bleeding disorder
Former first lady Nancy Reagan dies at 94